Eitan Lavie is an Academic Visitor at the Oxford Institute of Population Ageing, University of Oxford, from October 2026 to March 2027.

He is an international investor, entrepreneur and strategic adviser whose work spans venture capital, technology innovation, healthcare and healthy longevity, with extensive professional engagement across Europe and Asia.

He is Managing Partner of Artofin Venture Capital, where his investment interests include artificial intelligence, digital health, preventive medicine, diagnostics and technologies that may contribute to healthier and more functional lives. With a professional background in international commercial and securities law, Eitan brings an interdisciplinary perspective to the relationship between technological innovation, healthcare systems, investment and societal change.

His current research interests focus on two complementary areas. The first examines population ageing in Asia, with particular attention to Japan's experience in community-based prevention, functional independence, inequalities in healthy ageing and the potential relevance of these approaches to other ageing societies. The second explores the relationship between stress biology, physiological regulation, adaptation and recovery in the context of healthy longevity.

During his time at Oxford, Eitan aims to advance his independent research on ageing societies in Asia, deepen his engagement with the scientific literature, and exchange perspectives with researchers working across population ageing, public health, behavioural science and health innovation. He is particularly interested in connecting rigorous academic inquiry with practical experience from healthcare and technology ecosystems in Japan and Southeast Asia.